Skip to main content
. 2021 Nov 1;11(11):1615. doi: 10.3390/biom11111615

Figure 1.

Figure 1

(a) Comparison of mean SOD levels in plasma (P) and cerebrospinal fluid (CSF) in ICH patients and control group, SOD (P) in ICH and control: p = 0.023, mean SOD (P) and mean SOD (CSF): p = 0.008 (b) Development of SOD levels in P and CSF in ICH patients and control group (day 1, day 3, and day 7), SOD (CSF) at day 3 and control: p = 0.02 (c) Comparison of SOD in P (day 1 and 3) of patients with a favorable (0–3) and an unfavorable (4–6) mRS after 6 months (p = 0.04), p ≤ 0.05 *, p < 0.01 **, p < 0.001.